Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study (10.1007/s13300-021-01133-8, 2021)

Emral, RifatHaymana, CemDemirci, IbrahimTasci, IlkerSahin, MustafaCakal, ErmanAta, Naim2024-08-042024-08-0420211869-69531869-6961https://doi.org/10.1007/s13300-021-01154-3https://hdl.handle.net/11616/100217[Abstract Not Available]eninfo:eu-repo/semantics/openAccess[No Keywords]Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study (10.1007/s13300-021-01133-8, 2021)Correction1211287128723455940310.1007/s13300-021-01154-32-s2.0-85115635106Q1WOS:000698864600001Q3